Fresh2 Group Limited (NASDAQ:FRES – Get Free Report) was the recipient of a large drop in short interest during the month of October. As of October 15th, there was short interest totalling 8,600 shares, a drop of 50.0% from the September 30th total of 17,200 shares. Based on an average trading volume of 38,200 shares, the days-to-cover ratio is presently 0.2 days.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group raised shares of Fresh2 Group to a “strong-buy” rating in a report on Thursday, August 8th.
View Our Latest Stock Analysis on Fresh2 Group
Fresh2 Group Price Performance
Fresh2 Group Company Profile
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People’s Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc.
See Also
- Five stocks we like better than Fresh2 Group
- How to Find Undervalued Stocks
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- 3 Ways To Invest In Coffee, Other Than Drinking It
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Fresh2 Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh2 Group and related companies with MarketBeat.com's FREE daily email newsletter.